Concerted modulation of paxillin dynamics at focal adhesions by deleted in liver cancer-1 and focal adhesion kinase during early cell spreading

Cytoskeleton

Volumn 71, Issue 12, 2014, Pages 677-694

  Kaushik, Shelly ^a,b   Ravi, Archna ^a,b   Hameed, Feroz M ^b   Low, Boon Chuan ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cell dynamics; GTPase activating protein (GAP); RhoGTPases; Tumor suppressor

Indexed keywords

DELETED IN LIVER CANCER 1 PROTEIN; FOCAL ADHESION KINASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PAXILLIN; PROTEIN; UNCLASSIFIED DRUG; DLC1 PROTEIN, HUMAN; PXN PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL ADHESION; CELL MEMBRANE; CELL SPREADING; DOWN REGULATION; ENZYME MECHANISM; FEMALE; FIBROBLAST; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FOCAL ADHESION; HELA CELL LINE; HUMAN; HUMAN CELL; MODULATION; PREPUCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SPATIOTEMPORAL ANALYSIS; BLEACHING; CELL MOTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; IMMUNOBLOTTING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR INVASION;

CELL MOVEMENT; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GTPASE-ACTIVATING PROTEINS; HUMANS; IMMUNOBLOTTING; NEOPLASM INVASIVENESS; PAXILLIN; PHOTOBLEACHING; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84922678938     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21201     Document Type: Article

References (53)

1. Cao X, Voss C, Zhao B, Kaneko T, Li SS. 2012. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation. Proc Natl Acad Sci USA 109:1455-1460.
2. Chan LK, Ko FCF, Ng IOL, Yam JWP. 2009. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for tensin2 PTB domain interaction and is required for tumor-suppressive function. Plos One 2009:4:e5572.
3. Chen BH, Tzen JT, Bresnick AR, Chen HC. 2002. Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells. J Biol Chem 277:33857-33863.
4. Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. 2003. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem 278:10824-10830.
5. Clark EA, King WG, Brugge JS, Symons M, Hynes RO. 1998. Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 142:573-586.
6. Deakin NO, Turner CE. 2008. Paxillin comes of age. J Cell Sci 121(Pt 15):2435-2444.
7. Dubin-Thaler BJ, Giannone G, Dobereiner HG, Sheetz MP. 2004. Nanometer analysis of cell spreading on matrix-coated surfaces reveals two distinct cell states and STEPs. Biophys J 86:1794-1806.
8. Erlmann P, Schmid S, Horenkamp FA, Geyer M, Pomorski TG, Olayioye MA. 2009. DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain. Mol Biol Cell 20:4400-4411.
9. Frank SR, Adelstein MR, Hansen SH. 2006. GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal adhesion turnover. EMBO J 25:1848-1859.
10. Guilluy C, Garcia-Mata R, Burridge K. 2011. Rho protein crosstalk: another social network? Trends Cell Biol 21:718-726.
11. Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Ronde P. 2005. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J Cell Sci 118(Pt 19):4415-4425.
12. Hanna S, El-Sibai M. 2013. Signaling networks of Rho GTPases in cell motility. Cell Signal 25:1955-1961.
13. Healy KD, Hodgson L, Kim TY, Shutes A, Maddileti S, Juliano RL, Hahn KM, Harden TK, Bang YJ, Der CJ. 2008. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol Carcinog 47:326-337.
14. Heering J, Erlmann P, Olayioye MA. 2009. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration. Exp Cell Res 315:2505-2514.
15. Holeiter G, Heering J, Erlmann P, Schmid S, Jahne R, Olayioye MA. 2008. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. Cancer Res 68:8743-8751.
16. Homma Y, Emori Y. 1995. A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J 14:286-291.
17. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T. 1995. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377:539-544.
18. Kawai K, Iwamae Y, Yamaga M, Kiyota M, Ishii H, Hirata H, Homma Y, Yagisawa H. 2009. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells 14:227-241.
19. Kawai K, Kitamura S, Maehira K, Seike J, Yagisawa H. 2010. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2. Adv Enzyme Regul 50:202-215.
20. Kim TY, Healy KD, Der CJ, Sciaky N, Bang YJ, Juliano RL. 2008. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J Biol Chem 283:32762-32770.
21. Kim TY, Vigil D, Der CJ, Juliano RL. 2009. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev 28:77-83.
22. Ko FC, Chan LK, Man-Fong Sze K, Yeung YS, Yuk-Ting Tse E, Lu P, Yu MH, Oi-Lin Ng I, Yam JW. 2013. PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis. Nat Commun 4:1618.
23. Lauffenburger DA, Horwitz AF. 1996. Cell migration: a physically integrated molecular process. Cell 84:359-369.
24. Lawson C, Lim ST, Uryu S, Chen XL, Calderwood DA, Schlaepfer DD. 2012. FAK promotes recruitment of talin to nascent adhesions to control cell motility. J Cell Biol 196:223-232.
25. Lele TP, Thodeti CK, Pendse J, Ingber DE. 2008. Investigating complexity of protein-protein interactions in focal adhesions. Biochem Biophys Res Commun 369:929-934.
26. Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO. 2005. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci USA 102:15207-15212.
27. Li G, Du X, Vass WC, Papageorge AG, Lowy DR, Qian X. 2011. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci USA 108:17129-17134.
28. Liao YC, Lo SH. 2008. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J Biochem Cell Biol 40:843-847.
29. Liao YC, Si L, deVere White RW, Lo SH. 2007. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol 176:43-49.
30. Lippincott-Schwartz J, Altan-Bonnet N, Patterson GH. 2003. Photobleaching and photoactivation: following protein dynamics in living cells. Nat Cell Biol Suppl:S7-S14.
31. Mitra SK, Hanson DA, Schlaepfer DD. 2005. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6:56-68.
32. Mitra SK, Schlaepfer DD. 2006. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516-523.
33. Nagaraja GM, Kandpal RP. 2004. Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. Biochem Biophys Res Commun 313:654-665.
34. Panetti TS. 2002. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front Biosci 7:d143-d150.
35. Parsons JT. 2003. Focal adhesion kinase: the first ten years. J Cell Sci 116(Pt 8):1409-1416.
36. Qian X, Li G, Asmussen HK, Asnaghi L, Vass WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG, Lowy DR. 2007. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci USA 104:9012-9017.
37. Raftopoulou M, Hall A. 2004. Cell migration: Rho GTPases lead the way. Dev Biol 265:23-32.
38. Reits EA, Neefjes JJ. 2001. From fixed to FRAP: measuring protein mobility and activity in living cells. Nat Cell Biol 3:E145-E147.
39. Shen B, Delaney MK, Du X. 2012. Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction. Curr Opin Cell Biol 24:600-606.
40. Shih YP, Takada Y, Lo SH. 2012. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells. Mol Cancer Res 10:34-39.
41. Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C, Luzzio MJ, Cooper B, Kath JC, Roberts WG, et al. 2007. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 282:14845-14852.
42. Tomar A, Lim ST, Lim Y, Schlaepfer DD. 2009. A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells. J Cell Sci 122(Pt 11):1852-1862.
43. Tsubouchi A, Sakakura J, Yagi R, Mazaki Y, Schaefer E, Yano H, Sabe H. 2002. Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J Cell Biol 159:673-683.
44. Vega FM, Ridley AJ. 2008. Rho GTPases in cancer cell biology. FEBS Lett 582:2093-2101.
45. Vitale N, Patton WA, Moss J, Vaughan M, Lefkowitz RJ, Premont RT. 2000. GIT proteins, A novel family of phosphatidylinositol 3, 4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6. J Biol Chem 275:13901-13906.
46. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 2004. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6:154-161.
47. Wong CM, Lee JM, Ching YP, Jin DY, Ng IO. 2003. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res 63:7646-7651.
48. Yam JW, Ko FC, Chan CY, Jin DY, Ng IO. 2006. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res 66:8367-8372.
49. Yang XY, Guan M, Vigil D, Der CJ, Lowy DR, Popescu NC. 2009. p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities. Oncogene 28:1401-1409.
50. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. 1998. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58:2196-2199.
51. Zaidel-Bar R, Cohen M, Addadi L, Geiger B. 2004. Hierarchical assembly of cell-matrix adhesion complexes. Biochem Soc Trans 32(Pt3):416-420.
52. Zaidel-Bar R, Milo R, Kam Z, Geiger B. 2007. A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J Cell Sci 120(Pt 1):137-148.
53. Zhong D, Zhang J, Yang S, Soh UJ, Buschdorf JP, Zhou YT, Yang D, Low BC. 2009. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration. J Cell Sci 122(Pt 3):414-424.